Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Pfizer 14.451, Viking Therapeutics 0.
Pfizer vs Viking Therapeutics Net Worth and Market Cap
Pfizer (PFE) and Viking Therapeutics (VKTX) are peers in GLP-1. Pfizer reported revenue of $14.5B as of Q1 2026, compared with $0 for Viking Therapeutics. Pfizer leads on revenue.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Viking Therapeutics.| Metric | Pfizer | Viking Therapeutics |
|---|---|---|
| Market Cap | - | - |
| Revenue | $14.45B | $0 |
| Cost of Revenue | $4.73B | $0 |
| Gross Profit | $9.72B | $0 |
| Operating Income | $4.03B | $-164.00M |
| Net Income | $2.69B | $-158.00M |
| R&D Expense | $2.63B | $150.00M |
| Earnings Per Share | $0.47 | -$1.37 |
| Gross Margin | 67.3% | - |
| Operating Margin | 27.9% | - |
| Net Profit Margin | 18.6% | - |
| Free Cash Flow | $2.18B | $-114.00M |
| Cumulative Free Cash Flow | $356.40B | $-747.00M |
| Operating Cash Flow | $2.62B | $-114.00M |
| Cash & Equivalents | $1.70B | $118.00M |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.